Abstract
By targeting CD4+ effector T cells, HIV has a dramatic impact on the depletion, expansion and function of the different polarized T cell subsets. The maturation of T cell lineages is in part driven by intrinsic transcription factors that potentially influence how efficiently HIV replicates. In this review, we explore whether transcription factors that are required for polarizing T cells influence HIV replication. In particular, we examine provirus transcription as well as the establishment and maintenance of HIV latency. Furthermore, it is suggested these factors may provide novel cell-specific therapeutic strategies for targeting the HIV latent reservoir.
Keywords: CD4+ T cells, HIV, latency, transcription
Introduction
CD4+ effector T cell subsets possess diverse specialized functions. CD4+ T helper cells (TH1, TH2, TH17) are responsible for the production of cytokines stimulating specific immune responses. Follicular B helper T cells (TFH) support B cell activation, while regulatory T cells (Treg) suppress immune responses elicited by CD4+, CD8+ T cells and B cells.1–3 During infection, antigen-presenting cells (APC) display antigenic peptides in the context of MHC II to naïve CD4+ T cells (TH0), promoting their clonal expansion and polarization into effector T cells. A subset of activated CD4+ cells will generate memory T cells that are responsible for rapid recall of the adaptive immune response upon re-exposure. The differentiation of CD4+ T cells is driven in part by avidity of T cell receptor (TCR) engagement, strength of signaling, co-stimulatory signals and tissue microenvironments, including cytokine milieu and differential interactions with APC (Fig. 1).3 Additionally, CD4+ T cell development is controlled by a constellation of transcription factors that activate and repress batteries of genes that influence proliferation, differentiation and lineage commitment.1,2,4 Human immunodeficiency virus (HIV) infection decreases the overall number of CD4+ T cells and results in a general imbalance of all T cell populations, facilitating the immune dysregulation associated with autoimmune deficiency syndrome (AIDS).5–7 In addition to directly impacting the number of CD4+ T cells, HIV infection leads to indirect immune exhaustion by activating neighboring or bystander cells. Although all CD4+ T cells are susceptible to HIV infection due to their expression of CD4 and chemokine receptors, CXCR4 and CCR5, the ability of different T cell populations to support HIV replication varies,5–7 possibly reflecting differential expression of T cell-specific transcription factors that regulate HIV expression. It is possible that these T cell factors, by promoting HIV transcription, influence the dissemination of virus at different stages of AIDS. Alternatively, it is possible that by repressing proviral transcription they contribute to the establishment of latently infected T cells. Latently infected cells, which are the source of HIV rebound following interruption of antiretroviral treatments, present a major challenge to curing HIV infection.8,9 The mechanisms that establish HIV latency remain incompletely defined and research has focused on general events that control gene expression, including transcription initiation, elongation and epigenetic regulation of chromatin.8–10 Early attempts to purge HIV from the latent reservoir by targeting general biochemical pathways have had modest success; however, events regulated by T cell specific factors may provide a more cell-specific targeting strategy that would minimize potential off-target gene activation. This review highlights how key T cell restricted transcription factors impact HIV transcription in different T cell subsets.
Figure 1.
Model of Sequential CD4+ T Cell Differentiation. Upon activation by antigen presenting cell (APC), naïve T cell (TH0) undergoes differentiation into effector or memory populations. The different effector populations have capacity to mature into effector memory T cells (TEM). Stem cell memory T cells (TSCM), follicular helper T cells (TFH) and regulatory T cells (Treg) mature into central memory T cells (TCM), which then can become transitional memory T cells (TTM) and further convert into TEM.
Brief Overview of HIV Transcription
HIV transcription is regulated by multiple mechanisms and has been extensively reviewed.9–11 The upstream HIV-1 long terminal repeat (LTR) controls provirus transcription by functioning as a promoter/enhancer recruiting host transcription factors necessary to initiate transcription and co-activators, including histone acetyltransferases (HATs), Lysine (K)-specific demethylase (KDM) demethylases, and Switch/Sucrose nonfermentable (Swi/Snf) complexes, that regulate the chromatin organization of integrated provirus.10 However, transcriptional repressors are also recruited to the HIV LTR, such as the SUV39 family proteins and histone deacetylases (HDACs), which respectively methylate and deacetylate histones within positioned nucleosomes favoring condensation of chromatin and making the proviral LTR less accessible for efficient transcription. Furthermore, transcription of proviruses is inhibited at the step of transcription elongation. To overcome ribonucleic acid (RNA) polymerase II (RNAP II) promoter proximal pausing, HIV encodes a transcriptional activator, Tat, which in the context of the nascent RNA, binds a 5′ stem loop structure, TAR, and recruits P-TEFb, a complex that includes Cdk9 and cyclin T1, to the LTR. P-TEFb alleviates transcriptional repression by phosphorylating components of the paused RNAP II complex including the carboxyl terminal domain (CTD) of RNAP II, facilitating productive transcription elongation (Fig. 2). Strategies targeting signals that regulate recruitment of transcription factors, chromatin remodeling complexes, or regulators of RNAP II have been devised to activate and purge HIV latent reservoirs.8,9,12–15
Figure 2.
Model for HIV Transcriptional Regulation. During initiation of HIV transcription RNAP II is recruited to the HIV LTR and transcribes nascent TAR RNA. However, methyltransferases, HDACs, and transcriptional repressors bind to the HIV LTR resulting in paused RNAP II. Upon cell stimulation transcriptional activators and enhancers are recruited to HIV LTR, Tat binds to TAR RNA and recruits P-TEFb to activate RNAP II by phosphorylating its CTD. Histone modifying factors remodel and remove methyl groups from Nuc-0 and Nuc-1 making the chromatin more accessible to the transcriptional machinery.
TH1, TH2 and TH17 Cells and HIV Transcription
The polarization of TH1 verses TH2 cells is mediated by 2 primary factors, T-bet and GATA-3, respectively, whereas RORγt facilitates the differentiation of TH17 cells.3,16,17 TH1 cells have been reported to be limited in their ability to support HIV replication, although there is no evidence that T-bet, the TH1 master transcription factor, directly influences HIV transcription.18 T-bet antagonizes GATA-3 function, which is considered the key regulator of TH2 differentiation.3,17,19 GATA-3 binds to several sites in the HIV LTR and induces HIV transcription.20,21 Therefore, T-bet potentially limits HIV transcription by targeting GATA-3. In addition to GATA-3, c-Maf promotes TH2 differentiation22 and, in regards to HIV transcription, binds the HIV LTR and cooperates with NF-kB and Nuclear Factor of Activated T-cells (NFAT) to enhance HIV transcription.23 The ability of GATA-3 and c-Maf to activate HIV transcription is consistent with findings that TH2 cells support HIV replication.18,23 TH17 cells also support robust HIV replication, although RORγt and RORc, factors that are abundant in TH17 cells,18 have not been shown to directly impact HIV transcription; thus, the induction of downstream T cell signaling pathways that culminate in activation of NF-κB, NFAT and Signal Transducer and Activators of Transcription (STAT) probably strongly influence HIV transcription in TH17 cells.
Restricting or committing T cells towards specific functional subsets is in part regulated by the transcription factor Bcl-11b (also known as CTIP-2), which is a transcriptional repressor that is expressed in multiple T cell populations.24 In the context of HIV transcription, Bcl-11b binds the HIV LTR and limits transcription.25,26 One mechanism for this repression is that Bcl-11b recruits HDAC1, HDAC2, and SUV39H1 to the HIV LTR, resulting in deacetylation and methylation of the positioned nucleosome adjacent to the HIV transcriptional start site.25 Furthermore, Bcl-11b facilitates binding of hetero-chromatin protein 1 (HP1).25 Overall, these posttranslational changes and recruitment of factors promote the formation of heterochromatin at the viral promoter and transcriptional repression.25 Bcl-11b is also able to repress Tat-dependent transcription by binding Tat and redirecting it to heterochromatic regions.26,27 However, the question as to whether this factor directly contributes to HIV latency remains unresolved.
Treg Cells and HIV Transcription
There has been recent interest in characterizing the role of Treg cells in HIV.5,6 In general, changes in Treg numbers and function have been documented in patients and include higher Treg frequencies in untreated AIDS patients and diminished ability of these cells to suppress immune activation in HAART-treated patients.5,6 Whether these changes are a direct result of HIV infection or reflect more general immune dysfunction requires further investigation. Treg development is in part driven by the transcription factor FoxP3.3 The data as to whether FoxP3 directly impacts HIV transcription are conflicting. Ectopically expressed FoxP3 in primary CD4+ T cells inhibits activation and recruitment of transcriptional activators NF-κB, CREB and NFAT2 to the LTR.28,29 FoxP3 may also facilitate HIV transcription by inhibiting HDAC1.30,31 However, overexpression of FoxP3 in different T cell subsets may result in different transcriptional outcomes. For example, forced expression of FoxP3 polarized naïve CD4+ T cells towards a Treg phenotype and enhanced HIV replication, but had no impact on T memory cell phenotypes or HIV transcription.32 These conflicting results may reflect intrinsic differences between T cell subsets or challenges associated with overexpressing factors, and underscore the need to further study HIV transcription in primary Treg cells.
TFH Cells and HIV Transcription
TFH are essential for mediating T cell-dependent B cell responses. TFH cells also support productive HIV infection and are reported to expand during the course of HIV infection.33,34 Bcl-6 is the master transcription factor for the generation of TFH cells.35 Bcl-6 partly functions by inhibiting the expression and function of other transcriptional regulators that determine T cell subsets including GATA-3, T-bet, ROR-γt and Blimp-1.35,36 In particular, Bcl6 and Blimp-1 have an antagonistic relationship.37,38 Blimp-1 inhibits both T cell proliferation and differentiation into TFH and TH1 cells.37 Unlike Bcl-6, Blimp-1 is highly expressed in TH2 cells compared to TH1 cells and represses TH1 differentiation by repressing interferon, T-bet and Bcl-6 expression.39 Increased Blimp-1 levels correlate with enhanced expression of inhibitory molecules, such as PD-1, CTLA-4 and LAG3, in T cells exposed to HIV.40,41 In addition, Blimp-1 expression is increased in chronic HIV patients, but is not altered in long-term non-progressors.42 While the role of Bcl-6 and Blimp-1 in HIV transcription is unclear, it is tempting to speculate that Bcl-6 supports HIV replication, while Blimp-1 inhibits it, and that elevated Blimp-1 in CD4+ T cells might contribute to the establishment and maintenance of HIV latency (Fig. 3). Interestingly, the HIV LTR contains binding sites for both Bcl-6 and Blimp-1, suggesting that these factors directly regulate HIV transcription (reference 43 and Kaczmarek and Henderson unpublished observation).43
Figure 3.
Model for Potential Role of Bcl-6 and Blimp-1 in HIV Transcription. Blimp-1 and Bcl-6 have potential binding sites in the HIV LTR. We hypothesize that Bcl-6 favors the high expression of HIV in TFH cells, while Blimp-1, an antagonist of Bcl-6, contributes to paused RNAP II and thus to the establishment of HIV latency. See text for details.
Memory Cell Populations and HIV Latency
A unique feature of the adaptive immune response is the generation of memory. For CD4+ T cells, two distinct memory populations have been well-characterized based on the expression of surface markers, homing capacity and function upon reactivation; T central memory (TCM) and T effector memory (TEM) cells.2,44,45 Recently, stem cell memory T cells (TSCM) have been described in humans.46 These self-renewing memory CD4+ cells are reported to generate T memory and effector populations. The array of factors that influence the proliferation and generation of TSCM, TCM and TEM, including cytokines, signaling events and transcription factors, have not been fully elucidated. Critical transcription factors that regulate the generation and survival of TCM include Schnurri-2, STAT3, STAT5a TBR2, FOXO3a, Bmi1 and LKLF.47–53 Furthermore, Bach-2, IRF-1 and p27 (Kip1) have been suggested to suppress TEM differentiation.54–56 Relevant to HIV, memory cells, especially TCM and TSCM, have been implicated as primary reservoirs harboring latent provirus because they are susceptible to HIV infection, are long-lived and, with their ability to self-renew, may maintain and/or renew the pool of cells harboring latent provirus (reference 57 and personal communication Buzon and Lichterfeld).57 This homeostatic proliferation of infected TCM and TSCM in the absence of T cell activation and robust HIV transcription presents a major barrier to eradicating persistent HIV infection and underscores the need to characterize the tissue distribution and factors that regulate these different T cell memory subsets.58 The predisposition for HIV to establish latency in TCM may reflect the expression levels of transcription factors, TCM express T-bet59 and have lower levels of Cyclin T1 and phosphorylated CDK9, the two subunits of P-TEFb required for transcription elongation.60 However, TEM have increased expression of factors shown to activate HIV transcription including GATA-3, c-Maf and RORγt.61,62 It has been suggested that NFAT is critical for overcoming latency and induction of HIV transcription in different T cell subsets including TCM, although recent studies have questioned the role of NFAT in the reactivation of latent HIV.63–66 The discrepancy of what key check points limit HIV transcription in latently infected cells may reflect heterogeneity of memory cells, difference in cell culture conditions and isolation of cell subsets. The factors that repress transcription in T memory cells have not been defined but most likely include epigenetic factors such as HDACs or methyltransferases.8,9
Conclusions and Perspectives
In an effort to eradicate HIV infection, strategies to purge transcriptionally-repressed HIV provirus from latent reservoirs have been employed to complement current antiretroviral therapies.15 Recent therapeutic approaches have focused on overcoming the repressive effects of chromatin, which has been implicated as a key regulator of HIV transcription.8,9 For example, clinical trials have used HDAC inhibitors valproic acid67,68 and vorinostat,69 which, despite modest ability to induce HIV transcription in peripheral blood of HAART patients, did not decrease the HIV reservoir. The limited success of these initial trials probably reflects the complexity of the latent reservoir in regards to the cells that are included in this compartment, as well as the multiple mechanisms that establish and maintain latency.8–10 Chromatin remodeling, recruitment of transcriptional activators and coactivators, enhanced RNAP II processivity and defective viruses have been implicated as contributing factors to HIV latency.8–10 An additional confounder is that many of the factors that limit HIV transcription are general transcriptional regulators, which are necessary for normal gene expression. Targeting RNAP II, P-TEFb, and chromatin remodeling factors will likely be toxic, lack specificity, and have an impact on global gene expression. We suggest that T cell restricted transcription factors strongly influence HIV proviral transcription and that these factors may provide specific targets for eliminating latent HIV. For example, Blimp-1 and Bcl-11b are potential repressors of HIV transcription that are found in different T cell subsets, including those that harbor latent virus. Modulating the expression of these T cell transcriptional regulators or targeting their cofactors would be predicted to reactivate and potentially purge latent virus in specific T cell subpopulations without global T cell activation. However, further research is required to understand the mechanisms of repression of HIV transcription in different T cell subsets and to assess which T cell factors are the best candidates for the development of novel treatment strategies.
Acknowledgments
We thank Daniele Cary and Gillian Schiralli Lester, Boston University School of Medicine, for critical discussions and constructive feedback. In addition, we thank Dr. Mathias Lichterfeld, Ragon Institute, Massachusetts General Hospital, for discussing recent unpublished work cited in this manuscript.
Footnotes
FUNDING: This work was partly supported by NIH grant AI097117.
COMPETING INTERESTS: Authors disclose no potential conflicts of interest.
Author Contributions
Conceived and designed manuscript: KK, AM, AJH. Wrote first draft: KK, AM, AJH. Contributed to the writing of the manuscript: KK, AM, AJH. Agree with manuscript results and conclusions: KK, AM, AJH. Jointly developed the structure and arguments for the paper: KK, AM, AJH. Made critical revisions and approved final version: KK, AM, AJH. All authors reviewed and approved of the manuscript.
DISCLOSURES AND ETHICS
As a requirement of publication the authors have provided signed confirmation of their compliance with ethical and legal obligations including but not limited to compliance with ICMJE authorship and competing interests guidelines, that the article is neither under consideration for publication nor published elsewhere, of their compliance with legal and ethical guidelines concerning human and animal research participants (if applicable), and that permission has been obtained for reproduction of any copyrighted material. This article was subject to blind, independent, expert peer review. The reviewers reported no competing interests. Provenance: the authors were invited to submit this paper.
REFERENCES
- 1.Murphy KM, Stockinger B. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat Immunol. 2010;11(8):674–680. doi: 10.1038/ni.1899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.van Leeuwen EM, Sprent J, Surh CD. Generation and maintenance of memory CD4(+) T Cells. Curr Opin Immunol. 2009;21(2):167–172. doi: 10.1016/j.coi.2009.02.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (*) Ann Rev Immunol. 2010;28:445–489. doi: 10.1146/annurev-immunol-030409-101212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Yamane H, Paul WE. Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets. Immunol Rev. 2013;252(1):12–23. doi: 10.1111/imr.12032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Chevalier MF, Weiss L. The split personality of regulatory T cells in HIV infection. Blood. 2013;121(1):29–37. doi: 10.1182/blood-2012-07-409755. [DOI] [PubMed] [Google Scholar]
- 6.Moreno-Fernandez ME, Presicce P, Chougnet CA. Homeostasis and function of regulatory T cells in HIV/SIV infection. J Virol. 2012;86(19):10262–10269. doi: 10.1128/JVI.00993-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Paiardini M, Müller-Trutwin M. HIV-associated chronic immune activation. Immunol Rev. 2013;254(1):78–101. doi: 10.1111/imr.12079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Siliciano RF, Greene WC. HIV latency. Cold Spring Harb Perspect Med. 2011;1(1):a007096. doi: 10.1101/cshperspect.a007096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. The challenge of finding a cure for HIV infection. Science. 2009;323(5919):1304–1307. doi: 10.1126/science.1165706. [DOI] [PubMed] [Google Scholar]
- 10.Schiralli Lester GM Henderson AJ. Mechanisms of HIV Transcriptional Regulation and Their Contribution to Latency. Mol Biol Int. 2012;2012:614120. doi: 10.1155/2012/614120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Pierson T, McArthur J, Siliciano RF. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol. 2000;18:665–708. doi: 10.1146/annurev.immunol.18.1.665. [DOI] [PubMed] [Google Scholar]
- 12.Lafeuillade A. Eliminating the HIV reservoir. Curr HIV/AIDS Rep. 2012;9(2):121–131. doi: 10.1007/s11904-012-0115-y. [DOI] [PubMed] [Google Scholar]
- 13.Deeks SG, Autran B, Berkhout B, et al. International AIDS Society Scientific Working Group on HIV Cure Towards an HIV cure: a global scientific strategy. Nat Rev Immunol. 2012;12(8):607–614. doi: 10.1038/nri3262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Tyagi M, Bukrinsky M. Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication. Mol Med. 2012;18:1096–1108. doi: 10.2119/molmed.2012.00194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Margolis DM, Hazuda DJ. Combined approaches for HIV cure. Curr Opin HIV AIDS. 2013;8(3):230–235. doi: 10.1097/COH.0b013e32835ef089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Muranski P, Restifo NP. Essentials of Th17 cell commitment and plasticity. Blood. 2013;121(13):2402–2414. doi: 10.1182/blood-2012-09-378653. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Amsen D, Spilianakis CG, Flavell RA. How are T(H)1 and T(H)2 effector cells made? Curr Opin Immunol. 2009;21(2):153–160. doi: 10.1016/j.coi.2009.03.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Gosselin A, Monteiro P, Chomont N, et al. Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection. J Immunol. 2010;184(3):1604–1616. doi: 10.4049/jimmunol.0903058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Kanhere A, Hertweck A, Bhatia U, et al. T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements. Nat Commun. 2012;3:1268. doi: 10.1038/ncomms2260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Yang Z, Engel JD. Human T cell transcription factor GATA-3 stimulates HIV-1 expression. Nucleic Acids Res. 1993;21(12):2831–2836. doi: 10.1093/nar/21.12.2831. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Galio L, Briquet S, Cot S, Guillet JG, Vaquero C. Analysis of interactions between huGATA-3 transcription factor and three GATA regulatory elements of HIV-1 long terminal repeat, by surface plasmon resonance. Anal Biochem. 1997;253(1):70–77. doi: 10.1006/abio.1997.2367. [DOI] [PubMed] [Google Scholar]
- 22.Ho IC, Lo D, Glimcher LH. c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and - independent mechanisms. J Exp Med. 1998;188(10):1859–1866. doi: 10.1084/jem.188.10.1859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Zhang M, Clausell A, Robinson T, et al. Host factor transcriptional regulation contributes to preferential expression of HIV type 1 in IL-4-producing CD4 T cells. J Immunol. 2012;189(6):2746–2757. doi: 10.4049/jimmunol.1103129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Liu P, Li P, Burke S. Critical roles of Bcl11b in T-cell development and maintenance of T-cell identity. Immunol Rev. 2010;238(1):138–149. doi: 10.1111/j.1600-065X.2010.00953.x. [DOI] [PubMed] [Google Scholar]
- 25.Marban C, Suzanne S, Dequiedt F, et al. Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. EMBO J. 2007;26(2):412–423. doi: 10.1038/sj.emboj.7601516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Rohr O, Lecestre D, Chasserot-Golaz S, et al. Recruitment of Tat to heterochromatin protein HP1 via interaction with CTIP2 inhibits human immunodeficiency virus type 1 replication in microglial cells. J Virol. 2003;77(9):5415–5427. doi: 10.1128/JVI.77.9.5415-5427.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Le Douce V, Colin L, Redel L, et al. LSD1 cooperates with CTIP2 to promote HIV-1 transcriptional silencing. Nucleic Acids Res. 2012;40(5):1904–1915. doi: 10.1093/nar/gkr857. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Grant C, Oh U, Fugo K, et al. Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathways. PLoS Pathog. 2006;2(4):e33. doi: 10.1371/journal.ppat.0020033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Selliah N, Zhang M, White S, et al. FOXP3 inhibits HIV–1 infection of CD4 T-cells via inhibition of LTR transcriptional activity. Virology. 2008;381(2):161–167. doi: 10.1016/j.virol.2008.08.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Holmes D, Knudsen G, Mackey-Cushman S, Su L. FoxP3 enhances HIV-1 gene expression by modulating NFkappaB occupancy at the long terminal repeat in human T cells. J Biol Chem. 2007;282(22):15973–15980. doi: 10.1074/jbc.M702051200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Holmes D, Gao J, Su L. Foxp3 inhibits HDAC1 activity to modulate gene expression in human T cells. Virology. 2011;421(1):12–18. doi: 10.1016/j.virol.2011.09.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Oswald-Richter K, Grill SM, Shariat N, et al. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol. 2004;2(7):E198. doi: 10.1371/journal.pbio.0020198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Lindqvist M, van Lunzen J, Soghoian DZ, et al. Expansion of HIV-specific T follicular helper cells in chronic HIV infection. J Clin Invest. 2012;122(9):3271–3280. doi: 10.1172/JCI64314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Perreau M, Savoye AL, De Crignis E, et al. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J Exp Med. 2013;210(1):143–156. doi: 10.1084/jem.20121932. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Yu D, Rao S, Tsai LM, et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity. 2009;31(3):457–468. doi: 10.1016/j.immuni.2009.07.002. [DOI] [PubMed] [Google Scholar]
- 36.Kusam S, Toney LM, Sato H, Dent AL. Inhibition of Th2 differentiation and GATA-3 expression by BCL-6. J Immunol. 2003;170(5):2435–2441. doi: 10.4049/jimmunol.170.5.2435. [DOI] [PubMed] [Google Scholar]
- 37.Crotty S, Johnston RJ, Schoenberger SP. Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation. Nat Immunol. 2010;11(2):114–120. doi: 10.1038/ni.1837. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Martins G, Calame K. Regulation and functions of Blimp-1 in T and B lymphocytes. Annu Rev Immunol. 2008;26:133–169. doi: 10.1146/annurev.immunol.26.021607.090241. [DOI] [PubMed] [Google Scholar]
- 39.Cimmino L, Martins GA, Liao J, et al. Blimp-1 attenuates Th1 differentiation by repression of ifng, tbx21, and bcl6 gene expression. J Immunol. 2008;181(4):2338–2347. doi: 10.4049/jimmunol.181.4.2338. [DOI] [PubMed] [Google Scholar]
- 40.Che KF, Shankar EM, Muthu S, et al. p38 Mitogen-activated protein kinase/signal transducer and activator of transcription-3 pathway signaling regulates expression of inhibitory molecules in T cells activated by HIV-1-exposed dendritic cells. Mol Med. 2012;18:1169–1182. doi: 10.2119/molmed.2012.00103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Shankar EM, Che KF, Messmer D, Lifson JD, Larsson M. Expression of a broad array of negative costimulatory molecules and Blimp-1 in T cells following priming by HIV-1 pulsed dendritic cells. Mol Med. 2011;17(3–4):229–240. doi: 10.2119/molmed.2010.00175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Seddiki N, Phetsouphanh C, Swaminathan S, et al. The microRNA-9/B-lymphocyte-induced maturation protein-1/IL-2 axis is differentially regulated in progressive HIV infection. Eur J Immunol. 2013;43(2):510–520. doi: 10.1002/eji.201242695. [DOI] [PubMed] [Google Scholar]
- 43.Baron BW, Desai M, Baber LJ, et al. BCL6 can repress transcription from the human immunodeficiency virus type I promoter/enhancer region. Genes Chromosomes Cancer. 1997;19(1):14–21. [PubMed] [Google Scholar]
- 44.Pepper M, Jenkins MK. Origins of CD4(+) effector and central memory T cells. Nat Immunol. 2011;12(6):467–471. doi: 10.1038/ni.2038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004;22:745–763. doi: 10.1146/annurev.immunol.22.012703.104702. [DOI] [PubMed] [Google Scholar]
- 46.Gattinoni L, Lugli E, Ji Y, et al. A human memory T cell subset with stem cell-like properties. Nat Med. 2011;17(10):1290–1297. doi: 10.1038/nm.2446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Hirschhorn-Cymerman D, Budhu S, Kitano S, et al. Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype. J Exp Med. 2012;209(11):2113–2126. doi: 10.1084/jem.20120532. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.van Grevenynghe J, Procopio FA, He Z, et al. Transcription factor FOXO3a controls the persistence of memory CD4(+) T cells during HIV infection. Nat Med. 2008;14(3):266–274. doi: 10.1038/nm1728. [DOI] [PubMed] [Google Scholar]
- 49.Yamashita M, Kuwahara M, Suzuki A, et al. Bmi1 regulates memory CD4 T cell survival via repression of the Noxa gene. J Exp Med. 2008;205(5):1109–1120. doi: 10.1084/jem.20072000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Kuo CT, Veselits ML, Leiden JM. LKLF: A transcriptional regulator of single-positive T cell quiescence and survival. Science. 1997;277(5334):1986–1990. doi: 10.1126/science.277.5334.1986. [DOI] [PubMed] [Google Scholar]
- 51.Kimura MY, Iwamura C, Suzuki A, et al. Schnurri-2 controls memory Th1 and Th2 cell numbers in vivo. J Immunol. 2007;178(8):4926–4936. doi: 10.4049/jimmunol.178.8.4926. [DOI] [PubMed] [Google Scholar]
- 52.Catalfamo M, Di Mascio M, Hu Z, et al. HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. Proc Natl Acad Sci U S A. 2008;105(50):19851–19856. doi: 10.1073/pnas.0810032105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Juffroy O, Bugault F, Lambotte O, et al. Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway. J Virol. 2010;84(1):96–108. doi: 10.1128/JVI.01475-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.McElligott DL, Phillips JA, Stillman CA, Koch RJ, Mosier DE, Hobbs MV. CD4+ T cells from IRF-1-deficient mice exhibit altered patterns of cytokine expression and cell subset homeostasis. J Immunol. 1997;159(9):4180–4186. [PubMed] [Google Scholar]
- 55.Jatzek A, Tejera MM, Singh A, Sullivan JA, Plisch EH, Suresh M. p27(Kip1) negatively regulates the magnitude and persistence of CD4 T cell memory. J Immunol. 2012;189(11):5119–5128. doi: 10.4049/jimmunol.1201482. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Tsukumo SI, Unno M, Muto A, et al. Bach2 maintains T cells in a naive state by suppressing effector memory-related genes. Proc Natl Acad Sci U S A. 2013;110(26):10735–10740. doi: 10.1073/pnas.1306691110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Bosque A, Famiglietti M, Weyrich AS, Goulston C, Planelles V. Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells. PLoS Pathog. 2011;7(10):e1002288. doi: 10.1371/journal.ppat.1002288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Henrich TJ, Gandhi RT. Early Treatment and HIV-1 Reservoirs: A Stitch in Time? J Infect Dis. 2013 doi: 10.1093/infdis/jit307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Marshall HD, Chandele A, Jung YW, et al. Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4(+) cell properties during viral infection. Immunity. 2011;35(4):633–646. doi: 10.1016/j.immuni.2011.08.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Budhiraja S, Famiglietti M, Bosque A, Planelles V, Rice AP. Cyclin T1 and CDK9 T-loop phosphorylation are downregulated during establishment of HIV-1 latency in primary resting memory CD4+ T cells. J Virol. 2013;87(2):1211–1220. doi: 10.1128/JVI.02413-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Wang YH, Voo KS, Liu B, et al. A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med. 2010;207(11):2479–2491. doi: 10.1084/jem.20101376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Dutta A, Miaw SC, Yu JS, et al. Altered T-bet dominance in IFN-γ-decoupled CD4+ T cells with attenuated cytokine storm and preserved memory in influenza. J Immunol. 2013;190(8):4205–4214. doi: 10.4049/jimmunol.1202434. [DOI] [PubMed] [Google Scholar]
- 63.Robichaud GA, Barbeau B, Fortin JF, Rothstein DM, Tremblay MJ. Nuclear factor of activated T cells is a driving force for preferential productive HIV-1 infection of CD45RO-expressing CD4+ T cells. J Biol Chem. 2002;277(26):23733–23741. doi: 10.1074/jbc.M201563200. [DOI] [PubMed] [Google Scholar]
- 64.Pessler F, Cron RQ. Reciprocal regulation of the nuclear factor of activated T cells and HIV-1. Genes Immun. 2004;5(3):158–167. doi: 10.1038/sj.gene.6364047. [DOI] [PubMed] [Google Scholar]
- 65.Kinoshita S, Chen BK, Kaneshima H, Nolan GP. Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells. Cell. 1998;95(5):595–604. doi: 10.1016/s0092-8674(00)81630-x. [DOI] [PubMed] [Google Scholar]
- 66.Bosque A, Planelles V. Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. Blood. 2009;113(1):58–65. doi: 10.1182/blood-2008-07-168393. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Archin NM, Cheema M, Parker D, et al. Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection. PLoS One. 2010;5(2):e9390. doi: 10.1371/journal.pone.0009390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Routy JP, Tremblay CL, Angel JB, et al. Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical study. HIV Med. 2012;13(5):291–296. doi: 10.1111/j.1468-1293.2011.00975.x. [DOI] [PubMed] [Google Scholar]
- 69.Archin NM, Liberty AL, Kashuba AD, et al. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature. 2012;487(7408):482–485. doi: 10.1038/nature11286. [DOI] [PMC free article] [PubMed] [Google Scholar]



